Pcn322 - An Example of Rwe Used for Hta Evaluation: Erlotinib Renegotiation in Italy

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.404
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

PA2 Hospital-Based HTA in Italy: Diffusion and Potential Impact

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Early HTA in Pharmacogenomics: A Case Example in Cardiovascular Drugs

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Renegotiation and Relative Performance Evaluation: Why an Informative Signal May Be Useless

Review of Accounting Studies
AccountingManagementBusiness
2001English

Pmd163 - Hta of Artificial Urinary Sphincter (Aus) for the Treatment of Severe Male Post-Prostatectomy Incontinence in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Renegotiation: An Answer and Its Problems

University of Chicago Law Review
Law
1944English

An Evaluation of Different Coating for TiN Microelectrode Chambers Used for Neonatal Cardiomyocytes

2016English

The Renegotiation-Proofness Principle and Costly Renegotiation

SSRN Electronic Journal
2002English

Vertical Coordination Through Renegotiation

International Journal of Industrial Organization
Industrial RelationsIndustrialFinanceEconomicsManufacturing EngineeringStrategyManagementEconometricsAerospace Engineering
2012English

PCN37 Cost Comparison of Erlotinib Versus Generic Docetaxel in Second-Line Non-Small Cell Lung Cancer in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy